Regular article
Effects of Thalidomide and Related Metabolites in a Mouse Corneal Model of Neovascularization

https://doi.org/10.1006/exer.1997.0292Get rights and content

Abstract

Thalidomide, when administered orally, is an inhibitor of angiogenesis in the basic fibroblast growth factor (bFGF)-induced rabbit cornea micropocket assay. We now show in the mouse that thalidomide given intraperitoneally but not orally significantly inhibits bFGF-induced and vascular endothelial growth factor (VEGF)-induced corneal neovascularization. We further demonstrate that this inhibition is independent from thalidomide's ability to suppress tumor necrosis factor-alpha (TNF-alpha) production. Experiments examining thalidomide's enantiomers reveal that the S(-)-enantiomer has the strongest antiangiogenic activity in VEGF-induced and bFGF-induced corneal neovascularization. Structure activity studies suggest that thalidomide's anti-angiogenic activity is related to the open ring metabolites resulting from hydrolysis. Together these data support a correlation between thalidomide's antiangiogenic and teratogenic activities.

References (39)

  • Blascke, G. Kraft, H. P. Fickentscher, K. Köhler, F. 1979, Chromatographische racemattrennung von thalidomid und...
  • Cahen, R. 1964, Evaluation of the teratogenicity of drugs. Clin. Pharmacol. Ther. 5, 480,...
  • Carlesimo, M. Giustini, S. Rossi, A. Bonaccorsi, P. Calvieri, S. 1995, Treatment of cutaneous and pulmonary sarcoidosis...
  • D'Amato, R. J. Loughnan, M. S. Flynn, E. Folkman, J. 1994, Thalidomide is an inhibitor of angiogenesis. Proc. Natl....
  • Fabro, S. Smith, R. L. Williams, R. T. 1967a, The fate of [14, Biochem. J. 1045, 565,...
  • Fabro, S. Smith, R. Williams, R. 1967b, Toxicity and teratogenicity of optical isomers of thalidomide. Nature, 215,...
  • Ferrar, N. Henzel, W. J. 1989, Pituitary follicular cells secrete a novel heparin binding growth factor specific for...
  • Field, E. O. Gibbs, J. E. Tucker, D. L. Hellmann, K. 1966, Effect of thalidomide on graft-versus-host reaction. Nature,...
  • Friedlander, M. Brooks, P. C. Shaffer, R. W. Kincaid, C. M. Varner, J. A. Cheresh, D. A. 1995, Definition of two...
  • Gardner-Medwin, J. M. Smith, N. J. Powell, R. J. 1994, Clinical experience with thalidomide in the management of severe...
  • Gershbein, L. L. 1991, The thalidomide analog EM12, enhances 1,2-dimethyhydrazine induction of rat colon...
  • Guex-Crosier, Y. Pittet, N. Herbort, C. P. 1995, The effect of Thalidomide and Supidimide on endotoxin-induced uveitis...
  • Heger, W. Schmahl, H. Klug, S. Felies, A. Nau, H. Merker, H. Neubert, D. 1994, Embryotoxic effects of thalidomide...
  • Jackson, A. Schumacher, H. J. 1980, Identification of urinary metabolites of EM12N, Can. J. Pharmacol. Sci. 15 (2), 21,...
  • Kean, W. F. Lock, C. Howard-Lock, H. E. 1991, Chirality in antirheumatic drugs. Lancet, 338, 1565,...
  • Kenyon, B. M. Voest, E. E. Chen, C. Flynn, E. Folkman, J. D'Amato, R. J. 1996, A model of angiogenesis in the mouse...
  • Kocher-Becker, U. Kocher, W. 1982, Teratogenic activity of a hydrolytic thalidomide metabolite in mice....
  • Lenz, W. 1962, Thalidomide and congenital abnormalities. Lancet, 1,...
  • McBride, W. G. 1961, Thalidomide and congenital abnormalities. Lancet, 2,...
  • Cited by (448)

    • Thalidomide and analogues

      2019, Imides: Medicinal, Agricultural, Synthetic Applications and Natural Products Chemistry
    • Chemotherapy-induced bradycardia in oncology patients

      2019, Revista Colombiana de Cardiologia
    View all citing articles on Scopus
    f1

    Correspondence and reprint requests to: Robert J. D'Amato, Enders 1006, Department of Surgery, Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, U.S.A.

    View full text